ESLAW
Estrella Immunopharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.08
+3.33%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-1.3%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Feb 14, 2025 | Liu Cheng · director, officer: Chief Executive Officer | A-Award | 509,204 | $0.81 |
| Feb 14, 2025 | Liu Cheng · director, officer: Chief Executive Officer | A-Award | 490,796 | $0.81 |
| Feb 14, 2025 | Xu Jiandong · officer: Chief Financial Officer | A-Award | 509,204 | $0.81 |
| Feb 14, 2025 | Xu Jiandong · officer: Chief Financial Officer | A-Award | 490,796 | $0.81 |
| Mar 17, 2022 | Li Jianwei · officer: Co-Chief Executive Officer | Purchase | 141,970 | $314.7K |
Institutional positioning
13F filings over the trailing two quarters
New 0Increased 1Reduced 2Sold out 8
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | Unchanged | 189,899 | May 15, 2026 |
| D. E. SHAW & CO., INC. | Unchanged | 87,500 | May 15, 2026 |
| SKYVIEW INVESTMENT ADVISORS, LLC | Unchanged | 62,500 | May 15, 2026 |
| YAKIRA CAPITAL MANAGEMENT, INC. | Reduced | 46,285 | May 14, 2026 |
| WHITEBOX ADVISORS LLC | Unchanged | 42,293 | May 15, 2026 |
| CLEAR STREET GROUP INC. | Increased | 34,082 | May 15, 2026 |
| CITIGROUP INC | Unchanged | 30,000 | May 11, 2026 |
| TORONTO DOMINION BANK | Unchanged | 21,635 | May 15, 2026 |
| ROBERTSON STEPHENS WEALTH MANAGEMENT, LLC | Reduced | 12,000 | Apr 28, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | Sold Out | 0 | May 15, 2026 |
| D. E. Shaw & Co., Inc. | Sold Out | 0 | May 15, 2026 |
| Robertson Stephens Wealth Management, LLC | Sold Out | 0 | Apr 28, 2026 |
| Yakira Capital Management, Inc. | Sold Out | 0 | May 14, 2026 |
| CITIGROUP INC | Sold Out | 0 | May 11, 2026 |
| TORONTO DOMINION BANK | Sold Out | 0 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Feb 14, 2025